Trump Revives 2020 Drug Pricing Policy with Executive Order

President Donald Trump has announced the revival of his "most favored nation" policy aimed at drastically reducing U.S. prescription drug prices to match the lowest prices paid globally, promising cuts of 30% to 80%. This policy, initially attempted in 2020 but blocked by a federal judge and later rescinded by President Biden, is expected to face strong opposition from the pharmaceutical industry and skepticism from critics who question its effectiveness in achieving large Medicaid savings. Trump also claimed credit for mediating peace between India and Pakistan, emphasizing his administration's unconventional foreign policy approach that involves engaging with various global actors, including controversial groups, although some analysts question the equivalency he places on India and Pakistan given their different records. Meanwhile, efforts supported by the U.S. have targeted Hezbollah's influence in Lebanon by cracking down on smuggling operations and enhancing government control, reflecting a broader strategy to limit the group's power. Separately, a federal judge appeared inclined to temporarily block Trump's sweeping government restructuring plans, citing constitutional concerns about the president's authority to unilaterally implement major changes without congressional approval. These developments highlight Trump's continued push for bold domestic and international policies that provoke significant debate and legal challenges.